Skip to main content
. 2016 Aug 17;18(5):637–650. doi: 10.1007/s11307-016-0993-2

Fig. 1.

Fig. 1

Flow diagram of proposed randomised control trial (RCT) for evaluating novel imaging paradigms. Rather than demonstrating incremental value from single-injection, dual-imaging PET/CT-PET/MRI comparisons, an added value needs to be assessed from a management plan implementation (courtesy of R Hicks, Peter Mac Cancer Centre Melbourne, Australia).